Everything tagged "medical distribution" across research, earnings, and macro.
3 articles
Cencora, Inc. (COR) slumps after missing on EPS and revenue, but the full story goes beyond the headline. This deep-dive unpacks U.S. Healthcare Solutions pressure, international strength, margin shifts, and why raised EPS guidance couldn’t offset a revenue reset.
Cencora is using specialty expansion and GLP-1 volume to grow earnings faster than revenue. The stock looks constructive for medium-term investors, with solid guidance and a reasonable forward valuation.
Cencora, Inc. (COR) slumps 17.4% after reporting earnings misses, as investors react to weaker-than-expected results and pressure on the stock.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the Generator